Skip to main content
Veterinary Medicines

Aftovaxpur DOE (25) A24 Cruzeiro + A Turkey 14/98

Authorised
  • Foot-and-mouth disease virus, serotype A, strain A24 Cruzeiro, Inactivated
  • Foot-and-mouth disease virus, serotype A, strain Turkey 14/98, Inactivated

Identifikacija zdravila

Ime zdravila:
Aftovaxpur DOE (25) A24 Cruzeiro + A Turkey 14/98
Učinkovina:
Pot uporabe:
  • intramuskularna uporaba
  • Subkutana uporaba

Podatki o zdravilu

Učinkovina / Jakost:
  • Na voljo samo v English
    Presentation_strength:≥ 6 PD50 Reference:Hse Index:0
  • Na voljo samo v English
    Presentation_strength:≥ 6 PD50 Index:11
Farmacevtska oblika:
  • Emulzija za injiciranje
Withdrawal period by route of administration:
  • Intramuscular use
    • govedo
      • Not applicable
        0
        day
    • Sheep
      • Not applicable
        0
        day
    • Pig
      • Not applicable
        0
        day
  • Subcutaneous use
    • govedo
      • Not applicable
        0
        day
    • Sheep
      • Not applicable
        0
        day
    • Pig
      • Not applicable
        0
        day
Anatomsko-terapevtsko-kemična veterinarska oznaka (ATCvet):
  • QI02AA04
Status dovoljenja:
  • Valid
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Opis ovojnine:

Dodatne informacije

Entitlement type:
Imetnik dovoljenja za promet z zdravilom:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Proizvodna mesta, odgovorna za sproščanje serij:
  • Boehringer Ingelheim Animal Health France
Pristojni organ:
  • European Commission
Številka dovoljenja :
Ta podatek za to zdravilo ni na voljo.
Datum spremembe statusa dovoljenja:

Dokumenti

Combined File of all Documents

slovenščina (PDF)
Objavljeno na: 3/11/2022
Prenesi
Angleščina (PDF)
Objavljeno na: 3/11/2022
Bulgarian (PDF)
Objavljeno na: 3/11/2022
Croatian (PDF)
Objavljeno na: 3/11/2022
Czech (PDF)
Objavljeno na: 3/11/2022
Danish (PDF)
Objavljeno na: 3/11/2022
Dutch (PDF)
Objavljeno na: 3/11/2022
Estonian (PDF)
Objavljeno na: 3/11/2022
Finnish (PDF)
Objavljeno na: 3/11/2022
French (PDF)
Objavljeno na: 3/11/2022
German (PDF)
Objavljeno na: 3/11/2022
Greek (PDF)
Objavljeno na: 3/11/2022
Hungarian (PDF)
Objavljeno na: 3/11/2022
Icelandic (PDF)
Objavljeno na: 3/11/2022
Italian (PDF)
Objavljeno na: 3/11/2022
Latvian (PDF)
Objavljeno na: 3/11/2022
Lithuanian (PDF)
Objavljeno na: 3/11/2022
Maltese (PDF)
Objavljeno na: 3/11/2022
Norwegian (PDF)
Objavljeno na: 3/11/2022
Polish (PDF)
Objavljeno na: 3/11/2022
Portuguese (PDF)
Objavljeno na: 3/11/2022
Romanian (PDF)
Objavljeno na: 3/11/2022
Slovak (PDF)
Objavljeno na: 3/11/2022
Spanish (PDF)
Objavljeno na: 3/11/2022
Swedish (PDF)
Objavljeno na: 3/11/2022

ema-puar-aftovaxpur-v-2292-var-ii-0009-en.pdf

Angleščina (PDF)
Objavljeno na: 17/03/2023
Prenesi

ema-puar-aftovaxpur-v-2292-par-en.pdf

Angleščina (PDF)
Objavljeno na: 6/02/2023
Prenesi

ema-puar-aftovaxpur-v-2292-var-ii-0001-en.pdf

Angleščina (PDF)
Objavljeno na: 6/02/2023
Prenesi
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."